(Total Views: 417)
Posted On: 01/19/2019 7:02:55 PM
Post# of 98181
$RVXCF watch for news of financing...
Biggest risk imo is a lack of funds to deliver on what I see as multi-billion dollar potential for Phase III drug candidate Apabetalone. I don't think they'll have any trouble raising the money needed to advance toward full approval if their trial succeeds, but right now it is an uncertainty....expecting a pop with news of funding.
Biggest risk imo is a lack of funds to deliver on what I see as multi-billion dollar potential for Phase III drug candidate Apabetalone. I don't think they'll have any trouble raising the money needed to advance toward full approval if their trial succeeds, but right now it is an uncertainty....expecting a pop with news of funding.
(0)
(0)
Check out my blog if you like: Avoid The Bag
Scroll down for more posts ▼
